Tracking information is sent via email once your order has shipped
Phase 2 results (48 weeks): 1mg dose: 8.7% average weight loss 4mg dose: 17.1% average weight loss 8mg dose: 22.8% average weight loss 12mg dose: 24.2% average weight loss Placebo: 2.1% average weight loss These numbers came from a 48-week study period, six months shorter than the 72-week SURMOUNT trials
Arda-Pirincci P, Bolkent S (2011) The role of glucagon-like peptide-2 on apoptosis, cell proliferation, and oxidant-antioxidant system at a mouse model of intestinal injury induced by tumor necrosis factor-alpha/actinomycin D
Reviewed by Emily Bigby, MD, Physician with Ivim Health Medical Disclaimer: This content is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment
No differences in water intake were observed during the majority of the subsequent light phase, which began during hour 12 , but water intake was low during this period in all groups
Dispose of used needles in a proper sharps container